Gyre Therapeutics Inc (GYRE)

Operating Cash Flow Growth

-901.15%

Quarterly · Period ending:

GYRE logo

GYRE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-901.15%
GYRE Quarterly Cash from Operations YoY % (140.14% → -901.15%)
High-resolution chart · PNG

GYRE operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-901.1494%
2,565.1163%
-103.9521%
178.9976%
137.206%
-104.473%
-182.0833%
-77.895%
-223.8032%
-72.3145%
-92.0564%
204.1913%
136.8716%
15.8017%
339.2962%
66.3102%
38.9057%
136.9336%
20.0687%
-66.0517%
-32.9479%
-408.476%
-173.3836%
-42.9451%
-32.0077%
67.977%
10.2319%
-29.5927%
-54.6742%
-192.8921%
-42.6468%
-42.463%
-68.4007%
-18.9888%
-26.9238%
3.5232%
-20.8677%
9.5278%
3.2089%
-23.6447%
32.5181%
-6.6787%
-68.4797%
46.1418%
39.448%
70.0458%
72.6719%
20.9805%
14.4215%
-59.2918%
3.7324%
6.6712%
39.9192%
62.5703%
43.4897%
42.4645%
24.8363%
-12.9508%
-30.6415%
-6.434%
-588.6533%
-112.6442%
-33.9985%
-964.5293%
50.1711%
2,338.6877%
-142.8817%
123.6989%
20.2171%
-15.9431%
-12,132.4643%
-149.3138%
-38.1058%
-147.4254%
99.0914%
493.2556%
-49.458%
404.3108%
22.2771%
37.5459%
40.1062%
140.1359%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.